Geneoscopy
Geneoscopy, Inc. is a life sciences company developing diagnostic tests for gastrointestinal health. Their flagship product, ColoSense, is an FDA-approved, at-home colorectal cancer screening test using a proprietary RNA-based platform. The company also invests in diagnostic tests for inflammatory bowel disease.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $105M
Date: 08-Jan-2025
Investors: Bio-Rad Laboratories, Petrichor, Labcorp, Morningside Ventures, Lightchain Capital, NT Investments, Granger Management, Mercy Health, Tri Locum Partners
Markets: Healthtech, Diagnostics, Biotechnology, Genetics, Health Care
HQ: St. Louis, Missouri, United States
Founded: 2015
Website: https://geneoscopy.com/
LinkedIn: https://www.linkedin.com/company/geneoscopy
Twitter: https://twitter.com/GeneoscopyLLC
Facebook: https://www.facebook.com/GeneoscopyLLC/
Crunchbase: https://www.crunchbase.com/organization/geneoscopy
Leave a Comment
Comments
No comments yet.